Abstract
Objective 1) To investigate the effect of low blood pressure (BP), treated arterial hypertension (AHT), and untreated AHT on the ganglion cell-inner plexiform layer (GCIPL) and the retinal nerve fiber layer (RNFL) thickness of non-glaucomatous eyes and 2) to elucidate whether this effect is related to crossing the lower limit of retinal blood flow (RBF) autoregulation.
Design Cross-sectional, case-control.
Subjects We included 96 eyes of 96 ophthalmologically healthy subjects (age 50-65). Participants were prospectively recruited from a large-scale cohort study in the northern Netherlands (n=167,000; Lifelines Biobank). They were allocated to four groups (low BP, normal BP [controls], treated AHT, untreated AHT), based on information from previous visits and strict distribution criteria.
Methods Inner retinal layer thicknesses were obtained with optical coherence tomography (OCT). Fractal dimension of the superficial microvasculature was quantified with OCT-angiography and customized software. Central retinal vessel diameters were obtained from fundus images. BP and intraocular pressure measurements were also acquired. Measurements were combined with a validated physiological model to estimate vascular outcome measures. Structural and vascular metrics were compared across groups and mediation analysis was performed.
Main outcome measures Structural: macular GCIPL and RNFL (mRNFL), peripapillary RNFL (pRNFL) thickness. Vascular: RBF, retinal vascular resistance (RVR), autoregulatory reserve (AR).
Results Compared to controls, GCIPL was thinner in the low BP group (P=0.013), treated hypertensives (P=0.007), and untreated hypertensives (P=0.007). Treated hypertensives exhibited the thinnest mRNFL (P=0.001), temporal pRNFL (P=0.045), and inferior pRNFL (P=0.034). In multivariable analysis, RBF was mediating the association of GCIPL thickness with BP within the combined low BP group and controls (P=0.003), RVR together with AR were mediating the same association within the combined treated hypertensives and controls (P=0.001 and P=0.032), and RVR was mediating the association within the combined untreated antihypertensives and controls (P=0.022).
Conclusions We uncovered GCIPL and RNFL thinning related to both tails of the BP distribution. GCIPL thinning was associated with reduced RBF autoregulatory capacity. This predisposition to glaucomatous damage could explain the frequent epidemiological finding of increased glaucoma risk in certain subgroups, such as subjects with nocturnal BP dipping or aggressively treated AHT. Longitudinal studies could confirm this postulation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NL6103
Funding Statement
European Union's Horizon 2020 Innovative Training Networks Program, under the Marie Sklodowska-Curie grant, Project ID 675033. The funding organization had no role in the design, conduct, analysis, or publication of this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics board of the University Medical Center Groningen approved the study protocol (#NL61508.042.17).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail co-authors: n.m.jansonius{at}umcg.nl
Conflict of interest: No conflicting relationships exist for any author.
Financial support: European Union’s Horizon 2020 Innovative Training Networks Program, under the Marie Sklodowska – Curie grant, Project ID 675033. The funding organization had no role in the design, conduct, analysis, or publication of this research.
Meeting presentation: European Association for Vision and Eye Research (EVER); Nice, 3rd-6th October 2018.
Data Availability
Data is freely available upon request to the corresponding author (Konstantinos Pappelis).
Abbreviations/Acronyms
- AHT
- arterial hypertension;
- AR
- autoregulatory reserve;
- BMI
- body mass index;
- BP
- blood pressure;
- CRAE
- central retinal artery equivalent;
- CRVE
- central retinal vein equivalent;
- DBP
- diastolic blood pressure;
- FD
- fractal dimension;
- GCIPL
- ganglion cell-inner plexiform layer;
- IOP
- intraocular pressure;
- IQR
- interquartile range;
- LARL
- lower autoregulation limit;
- MAP
- mean arterial pressure;
- mRNFL
- macular retinal nerve fiber layer;
- NTG
- normal-tension glaucoma;
- OCT
- optical coherence tomography;
- OCT-A
- optical coherence tomography-angiography;
- ONH
- optic nerve head;
- OPP
- ocular perfusion pressure;
- pRNFL
- peripapillary retinal nerve fiber layer;
- RBF
- retinal blood flow;
- RGC
- retinal ganglion cell;
- RNFL
- retinal nerve fiber layer;
- RPP
- retinal perfusion pressure;
- RVR
- retinal vascular resistance;
- SBP
- systolic blood pressure;
- SD
- standard deviation;
- SEQ
- spherical equivalent.
